Cargando…
Loss of Blood-Brain Barrier Integrity in an In Vitro Model Subjected to Intermittent Hypoxia: Is Reversion Possible with a HIF-1α Pathway Inhibitor?
Several sleep-related breathing disorders provoke repeated hypoxia stresses, which potentially lead to neurological diseases, such as cognitive impairment. Nevertheless, consequences of repeated intermittent hypoxia on the blood-brain barrier (BBB) are less recognized. This study compared two method...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003655/ https://www.ncbi.nlm.nih.gov/pubmed/36902491 http://dx.doi.org/10.3390/ijms24055062 |
_version_ | 1784904654910390272 |
---|---|
author | Voirin, Anne Cloé Chatard, Morgane Briançon-Marjollet, Anne Pepin, Jean Louis Perek, Nathalie Roche, Frederic |
author_facet | Voirin, Anne Cloé Chatard, Morgane Briançon-Marjollet, Anne Pepin, Jean Louis Perek, Nathalie Roche, Frederic |
author_sort | Voirin, Anne Cloé |
collection | PubMed |
description | Several sleep-related breathing disorders provoke repeated hypoxia stresses, which potentially lead to neurological diseases, such as cognitive impairment. Nevertheless, consequences of repeated intermittent hypoxia on the blood-brain barrier (BBB) are less recognized. This study compared two methods of intermittent hypoxia induction on the cerebral endothelium of the BBB: one using hydralazine and the other using a hypoxia chamber. These cycles were performed on an endothelial cell and astrocyte coculture model. Na-Fl permeability, tight junction protein, and ABC transporters (P-gp and MRP-1) content were evaluated with or without HIF-1 inhibitors YC-1. Our results demonstrated that hydralazine as well as intermittent physical hypoxia progressively altered BBB integrity, as shown by an increase in Na-Fl permeability. This alteration was accompanied by a decrease in concentration of tight junction proteins ZO-1 and claudin-5. In turn, microvascular endothelial cells up-regulated the expression of P-gp and MRP-1. An alteration was also found under hydralazine after the third cycle. On the other hand, the third intermittent hypoxia exposure showed a preservation of BBB characteristics. Furthermore, inhibition of HIF-1α with YC-1 prevented BBB dysfunction after hydralazine treatment. In the case of physical intermittent hypoxia, we observed an incomplete reversion suggesting that other biological mechanisms may be involved in BBB dysfunction. In conclusion, intermittent hypoxia led to an alteration of the BBB model with an adaptation observed after the third cycle. |
format | Online Article Text |
id | pubmed-10003655 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100036552023-03-11 Loss of Blood-Brain Barrier Integrity in an In Vitro Model Subjected to Intermittent Hypoxia: Is Reversion Possible with a HIF-1α Pathway Inhibitor? Voirin, Anne Cloé Chatard, Morgane Briançon-Marjollet, Anne Pepin, Jean Louis Perek, Nathalie Roche, Frederic Int J Mol Sci Article Several sleep-related breathing disorders provoke repeated hypoxia stresses, which potentially lead to neurological diseases, such as cognitive impairment. Nevertheless, consequences of repeated intermittent hypoxia on the blood-brain barrier (BBB) are less recognized. This study compared two methods of intermittent hypoxia induction on the cerebral endothelium of the BBB: one using hydralazine and the other using a hypoxia chamber. These cycles were performed on an endothelial cell and astrocyte coculture model. Na-Fl permeability, tight junction protein, and ABC transporters (P-gp and MRP-1) content were evaluated with or without HIF-1 inhibitors YC-1. Our results demonstrated that hydralazine as well as intermittent physical hypoxia progressively altered BBB integrity, as shown by an increase in Na-Fl permeability. This alteration was accompanied by a decrease in concentration of tight junction proteins ZO-1 and claudin-5. In turn, microvascular endothelial cells up-regulated the expression of P-gp and MRP-1. An alteration was also found under hydralazine after the third cycle. On the other hand, the third intermittent hypoxia exposure showed a preservation of BBB characteristics. Furthermore, inhibition of HIF-1α with YC-1 prevented BBB dysfunction after hydralazine treatment. In the case of physical intermittent hypoxia, we observed an incomplete reversion suggesting that other biological mechanisms may be involved in BBB dysfunction. In conclusion, intermittent hypoxia led to an alteration of the BBB model with an adaptation observed after the third cycle. MDPI 2023-03-06 /pmc/articles/PMC10003655/ /pubmed/36902491 http://dx.doi.org/10.3390/ijms24055062 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Voirin, Anne Cloé Chatard, Morgane Briançon-Marjollet, Anne Pepin, Jean Louis Perek, Nathalie Roche, Frederic Loss of Blood-Brain Barrier Integrity in an In Vitro Model Subjected to Intermittent Hypoxia: Is Reversion Possible with a HIF-1α Pathway Inhibitor? |
title | Loss of Blood-Brain Barrier Integrity in an In Vitro Model Subjected to Intermittent Hypoxia: Is Reversion Possible with a HIF-1α Pathway Inhibitor? |
title_full | Loss of Blood-Brain Barrier Integrity in an In Vitro Model Subjected to Intermittent Hypoxia: Is Reversion Possible with a HIF-1α Pathway Inhibitor? |
title_fullStr | Loss of Blood-Brain Barrier Integrity in an In Vitro Model Subjected to Intermittent Hypoxia: Is Reversion Possible with a HIF-1α Pathway Inhibitor? |
title_full_unstemmed | Loss of Blood-Brain Barrier Integrity in an In Vitro Model Subjected to Intermittent Hypoxia: Is Reversion Possible with a HIF-1α Pathway Inhibitor? |
title_short | Loss of Blood-Brain Barrier Integrity in an In Vitro Model Subjected to Intermittent Hypoxia: Is Reversion Possible with a HIF-1α Pathway Inhibitor? |
title_sort | loss of blood-brain barrier integrity in an in vitro model subjected to intermittent hypoxia: is reversion possible with a hif-1α pathway inhibitor? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003655/ https://www.ncbi.nlm.nih.gov/pubmed/36902491 http://dx.doi.org/10.3390/ijms24055062 |
work_keys_str_mv | AT voirinannecloe lossofbloodbrainbarrierintegrityinaninvitromodelsubjectedtointermittenthypoxiaisreversionpossiblewithahif1apathwayinhibitor AT chatardmorgane lossofbloodbrainbarrierintegrityinaninvitromodelsubjectedtointermittenthypoxiaisreversionpossiblewithahif1apathwayinhibitor AT brianconmarjolletanne lossofbloodbrainbarrierintegrityinaninvitromodelsubjectedtointermittenthypoxiaisreversionpossiblewithahif1apathwayinhibitor AT pepinjeanlouis lossofbloodbrainbarrierintegrityinaninvitromodelsubjectedtointermittenthypoxiaisreversionpossiblewithahif1apathwayinhibitor AT pereknathalie lossofbloodbrainbarrierintegrityinaninvitromodelsubjectedtointermittenthypoxiaisreversionpossiblewithahif1apathwayinhibitor AT rochefrederic lossofbloodbrainbarrierintegrityinaninvitromodelsubjectedtointermittenthypoxiaisreversionpossiblewithahif1apathwayinhibitor |